Startups
Edit
Aureka Biotechnologies, Inc.
https://www.aurekabio.com/Last activity: 02.09.2026
Probably Closed
Aureka Biotechnologies is a biotech startup democratizing the pharmaceutical industry through our focused area of immunotherapeutic discovery. Empowered by our integrated digital biology and AI solutions, we enable partners to bring new medicines to patients efficiently. By integrating microfluidics, synthetic biology, and AI, we've developed a powerful drug discovery platform, accelerating the path from concept to market.
Overview
Location
United States, California, Laguna Hills
Employees
11-50
Total raised
$10M
Founded date
2023
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 27, 2026 | Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result | SHANGHAI and LAGUNA HILLS, Calif., Aug. 27, 2026 /PRNewswire/ -- The complete results of AIntibody, the first international AI antibody design competition, have now been formally published in Nature Biotechnology. Figure 1 | Screenshot of t... |
| Aug 11, 2026 | Aureka Biotechnologies Closes New Funding | Aureka Biotechnologies, a Cambridge, MA-based provider of an AI-native TechBio platform for drug discovery, raised an undisclosed amount in new funding. The round was led by Granite Asia and HighLight Capital (HLC) with participation from M... |
| Aureka Biotechnologies | “To improve human health through digitalizing therapeutic discovery” |
Reviews 0
FAQ about Aureka Biotechnologies, Inc.
When was Aureka Biotechnologies, Inc. founded?
Aureka Biotechnologies, Inc. was founded in 2023.
How much funding has Aureka Biotechnologies, Inc. raised?
Aureka Biotechnologies, Inc. has raised $10M in total across 1 funding round.
What has the press written about Aureka Biotechnologies, Inc.?
Parsers VC has collected 4 articles mentioning Aureka Biotechnologies, Inc., among them “Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result” (Aug 27, 2026) and “Aureka Biotechnologies Closes New Funding” (Aug 11, 2026).
Is Aureka Biotechnologies, Inc. still active?
Aureka Biotechnologies, Inc. is probably closed: its latest activity on Parsers VC dates from Sep 2, 2026.